Tag: nasdaq

FDA Approves Apellis EMPAVELI (pegcetacoplan) as the First C3G and Primary IC-MPGN Treatment for Patients 12 and Older

Proven efficacy across all three key markers of disease—68% reduction in proteinuria,…

GlobeNews Wire

Portage Biotech Reports Results for Fiscal Year Ended March 31, 2025

July 25, 2025 16:15 ET  | Source: Portage Biotech Inc. DOVER, Del.,…

GlobeNews Wire

Diginex Announces Execution of Warrants Agreement, Bonus Share Issuance and Cancelation of EGM

July 25, 2025 20:00 ET  | Source: Diginex Limited LONDON, July 25,…

GlobeNews Wire

SIMPPLE Ltd. Fully Regains Compliance with Nasdaqs Continued Listing Requirements

Singapore, July 24, 2025 (GLOBE NEWSWIRE) -- SIMPPLE Ltd. (NASDAQ: SPPL) (“SIMPPLE”…

GlobeNews Wire

UPDATEBrag House Announces $15 Million Private Placement

NEW YORK, July 24, 2025 (GLOBE NEWSWIRE) -- Brag House Holdings, Inc.…

GlobeNews Wire

Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

July 18, 2025 16:30 ET  | Source: Ultragenyx Pharmaceutical Inc. NOVATO, Calif.,…

GlobeNews Wire

HOOKIPA Pharma Announces Intention to Voluntarily Delist and Deregister its Common Stock

July 18, 2025 16:05 ET  | Source: HOOKIPA Pharma Inc. NEW YORK…

GlobeNews Wire

ALT Investors Have Opportunity to Join Altimmune, Inc. Fraud Investigation with the Schall Law Firm

LOS ANGELES--(BUSINESS WIRE)--$ALT--The Schall Law Firm, a national shareholder rights litigation firm,…

Business Wire